The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study

psilocybin (COMP360) - Compass Pathways

G.M. Goodwin1; L. Marwood1; S. Mistry1; A. Nowakowska1; Z. Shabir1; H. Simmons1; E. Teoh1; J. Tsai1; E. Malievskaia1

Sep 30, 2023